HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER		Author Keyword(s) Vol Page [Advanced]

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this link to a friend Similar articles in this journal Similar articles in PubMed Add article to my folders Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Booth, J C L Articles by Neuberger, J Search for Related Content PubMed PubMed Citation Articles by Booth, J C L Articles by Neuberger, J

Gut 2001;49(Suppl I):I1-I21 ( July )

Clinical guidelines on the management of hepatitis C

J C L Booth^a, J O'Grady^b, J Neuberger^c, on behalf of the Royal College of Physicians of London and the British Society of Gastroenterology

^a Department of Gastroenterology, Royal Berkshire Hospital, London Road, Reading RG5 5AN, UK, ^b Institute of Liver Studies, King's College London, Bessemer Road, London SE5 9PJ, UK, ^c The Liver and Hepatobiliary Unit, Queen Elizabeth Hospital, Birmingham B15 2TH, UK

Correspondence to: Dr J C L Booth.

The first 150 words of the full text of this article appear below.

	1.0 Guidelines

1.1 THE NEED FOR GUIDELINES
Hepatitis C virus (HCV) is a major health care concern in the UK affecting some 200 000 to 400 000 individuals. The majority of these patients will have chronic HCV infection and many will develop chronic liver disease with the risk of developing cirrhosis and hepatocellular carcinoma (HCC). Successful treatment will arrest the progression of liver disease and so prevent the serious complications of chronic HCV infection. In addition, treatment will reduce the numbers of HCV infected individuals.

The relatively high cost of treatment enforces the need for a systematic approach for this condition so that resources are used most effectively. The development of clinical guidelines is important, as these will assist purchasing authorities, providers, clinicians, primary care groups, and patients in making decisions about appropriate treatment.

1.2 THE DEVELOPMENT OF GUIDELINES: RIGOUR OF DEVELOPMENT/SYSTEMATIC CRITICAL REVIEW OF THE LITERATURE

1.2.1 Guideline development group
The development of . . . [Full text of this article]

This article has been cited by other articles:

				A. A Butt, A. C Justice, M. Skanderson, M. O Rigsby, C. B Good, and C K. Kwoh Rate and predictors of treatment prescription for hepatitis C Gut, March 1, 2007; 56(3): 385 - 389. [Abstract] [Full Text] [PDF]

				I Gee and G Alexander Liver transplantation for hepatitis C virus related liver disease Postgrad. Med. J., December 1, 2005; 81(962): 765 - 771. [Abstract] [Full Text] [PDF]

				L. A. Adams, M. Bulsara, E. Rossi, B. DeBoer, D. Speers, J. George, J. Kench, G. Farrell, G. W. McCaughan, and G. P. Jeffrey Hepascore: An Accurate Validated Predictor of Liver Fibrosis in Chronic Hepatitis C Infection Clin. Chem., October 1, 2005; 51(10): 1867 - 1873. [Abstract] [Full Text] [PDF]

				V Lo Re III and J R Kostman Management of chronic hepatitis C Postgrad. Med. J., June 1, 2005; 81(956): 376 - 382. [Abstract] [Full Text] [PDF]

				R. Chou, E. C. Clark, and M. Helfand Screening for Hepatitis C Virus Infection: A Review of the Evidence for the U.S. Preventive Services Task Force Ann Intern Med, March 16, 2004; 140(6): 465 - 479. [Abstract] [Full Text] [PDF]

				C Skipper, J M Guy, J Parkes, P Roderick, and W M Rosenberg Evaluation of a prison outreach clinic for the diagnosis and prevention of hepatitis C: implications for the national strategy Gut, October 1, 2003; 52(10): 1500 - 1504. [Abstract] [Full Text] [PDF]

				A H Mohsen and P Easterbrook Hepatitis C testing in HIV infected patients Sex. Transm. Inf., February 1, 2003; 79(1): 76 - 76. [Full Text] [PDF]

				J L Brown HCV infection should be managed in specialist centres Gut, November 1, 2002; 51(5): 626 - 627. [Full Text] [PDF]